Conditions where inhibition of gastric acid secretion may be beneficial, including aspiration syndromes, dyspepsia, GERD, PUD & Zollinger-Ellison syndrome.
May alter metabolism of drugs metabolized by CYP2C19 isoenzymes. May prolong elimination of diazepam, phenytoin, tolbutamide & warfarin. May reduce absorption of drugs whose absorption is dependent on acid gastric pH eg, ketoconazole & possibly itraconazole. Increased plasma conc w/ voriconazole.
A02BC02 - pantoprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Sign Out
